• 1
    Parkin D, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74108.
  • 2
    Sherris J, Herdman C, Elias C. Cervical cancer in the developing world. West J Med 2001; 175: 23133.
  • 3
    Anderson GH, Boyes DA, Benedet JL, Le Riche JC, Matisic JP, Suen KC, Worth AJ, Millner A, Bennett OM. Organisation and results of the cervical cytology screening programme in British Columbia, 1955–85. Br Med J (Clin Res Ed) 1988; 296: 9758.
  • 4
    Benedet JL, Anderson GH, Matisic JP, Miller DM. A quality-control program for colposcopic practice. Obstet Gynecol 1991; 78: 8725.
  • 5
    American Cancer Society Guidelines for the Early Detection of Cancer. Available at: Accessed October 1, 2010.
  • 6
    Kurman R, Henson D, Herbst A, Noller K, Schiffman M. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA 1994; 271: 18669.
  • 7
    Sokolov K, Follen M, Richards-Kortum R. Optical spectroscopy for detection of neoplasia. Curr Opin Chem Biol 2002; 6: 6518.
  • 8
    Drezek RA, Richards-Kortum R, Brewer MA, Feld MS, Pitris C, Ferenczy A, Faupel ML, Follen M. Optical imaging of the cervix. Cancer 2003; 98: 201527.
  • 9
    Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, Hingmire S, Malvi SG, Thorat R, Kothari A, Chinoy R, Kelkar R, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360: 138594.
  • 10
    Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl B, Zhang WH, Peck RB, Li L, Chen F, Pan QJ, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008; 9: 92936.
  • 11
    Muñoz N, Bosch F, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, Shah K, Meijer C. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004; 111: 27885.
  • 12
    Franco EL, Harper DM. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine 2005; 23: 238894.
  • 13
    Littenberg B. Technology assessment in medicine. Acad Med 1992; 67: 4248.
  • 14
    Wright TC, Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 2007; 197: 3405.
  • 15
    Brookner C, Utzinger U, Follen M, Richards-Kortum R, Cox D, Atkinson EN. Effects of biographical variables on cervical fluorescence emission spectra. J Biomed Opt 2003; 8: 47983.
  • 16
    Brookner C, Follen M, Boiko I, Galvan J, Thomsen S, Malpica A, Suzuki S, Lotan R, Richards-Kortum R. Autofluorescence patterns in short-term cultures of normal cervical tissue. Photochem Photobiol 2000; 71: 73036.
  • 17
    Ramanujam N, Richards-Kortum R, Thomsen S, Mahadevan-Jansen A, Follen M, Chance B. Low temperature fluorescence imaging of freeze-trapped human cervical tissues. Opt Express 2001; 8: 33543.
  • 18
    Drezek R, Brookner C, Pavlova I, Bioko I, Malpica A, Lotan R, Follen M, Richards-Kortum R. Autofluorescence microscopy of fresh cervical-tissue sections reveals alterations in tissue biochemistry with dysplasia. Photochem Photobiol 2001; 73: 63641.
  • 19
    Drezek R, Sokolov K, Utzinger U, Boiko I, Malpica A, Lotan R, Follen M, Richards-Kortum R. Understanding the contributions of NADH and collagen to cervical tissue fluorescence spectra: modeling, measurements, and implication. J Biomed Opt 2001; 6: 38596.
  • 20
    Arifler D, Pavlova I, Gillenwater A, Richards-Kortum R. Light scattering from collagen fiber networks: micro-optical properties of normal and neoplastic stroma. Biophys J 2007; 92: 326074.
  • 21
    Drezek R, Guillaud M, Collier T, Boiko I, Malpica A, Macaulay C, Follen M, Richards-Kortum R. Light scattering from cervical cells throughout neoplastic progression: influence of nuclear morphology, DNA content, and chromatin texture. J Biomed Opt 2003; 8: 716.
  • 22
    Chang SK, Follen M, Malpica A, Utzinger U, Staerkel GA, Cox D. Optimal excitation wavelengths for discrimination of cervical neoplasia. IEEE Trans Biomed Eng 2002; 49: 110211.
  • 23
    Pavlova I, Sokolov K, Drezek R, Malpica A, Follen M, Richards-Kortum R. Microanatomical and biochemical origins of normal and precancerous cervical autofluorescence using laser-scanning fluorescence confocal microscopy. Photochem Photobiol 2003; 77: 5505.
  • 24
    Chang SK, Arifler D, Drezek R, Follen M, Richards-Kortum R. Analytical model to describe fluorescence spectra of normal and preneoplastic epithelial tissue: comparison with Monte Carlo simulations and clinical measurements. J Biomed Opt 2004; 9: 51122.
  • 25
    Chang SK, Mirabal YN, Atkinson EN, Cox D, Malpica A, Follen M, Richards-Kortum R. Combined reflectance and fluorescence spectroscopy for in vivo detection of cervical pre-cancer. J Biomed Opt 2005; 10: 024031.
  • 26
    Arifler D, MacAulay C, Follen M, Richards-Kortum R. Spatially resolved reflectance spectroscopy for diagnosis of cervical precancer: Monte Carlo modeling and comparison to clinical measurements. J Biomed Opt 2006; 11: 064027.
  • 27
    Chang SK, Marin N, Follen M, Richards-Kortum R. Model-based analysis of clinical fluorescence spectroscopy for in vivo detection of cervical intraepithelial dysplasia. J Biomed Opt 2006; 11: 024008.
  • 28
    Brookner C, Agrawal A, Trujillo E, Mitchell M, Richards-Kortum R. Safety analysis: relative risks of ultraviolet exposure from fluorescence spectroscopy and colposcopy are comparable. Photochem Photobiol 1997; 65: 10205.
  • 29
    Lee JS, Shuhatovich O, Price R, Pikkula B, Follen M, McKinnon N, Macaulay C, Knight B, Richards-Kortum R, Cox DD. Design and preliminary analysis of a study to assess intra-device and inter-device variability of fluorescence spectroscopy instruments for detecting cervical neoplasia. Gynecol Oncol 2005; 99: S98S111.
  • 30
    Pikkula BM, Shuhatovich O, Price RL, Serachitopol DM, Follen M, McKinnon N, MacAulay C, Richards-Kortum R, Lee JS, Atkinson EN, Cox DD. Instrumentation as a source of variability in the application of fluorescence spectroscopic devices for detecting cervical neoplasia. J Biomed Opt 2007; 12: 034014.
  • 31
    Pikkula B, Serachitopol D, MacAulay C, Mackinnon N, Lee JS, Cox D, Atkinson E, Follen M, Richards-Kortum R. Multicenter clinical trials of in vivo fluorescence: are the measurements equivalent? Proc SPIE 2007; 6430: 64301Q.
  • 32
    Nath A, Rivoire K, Chang S, Cox D, Atkinson EN, Richards-Kortum R. Effect of probe pressure on cervical fluorescence spectroscopy measurements. J Biomed Opt 2004; 9: 52333.
  • 33
    Rivoire K, Nath A, Cox D, Atkinson EN, Richards-Kortum R, Follen M. The effects of repeated spectroscopic pressure measurements on fluorescence intensity in the cervix. Am J Obstet Gynecol 2004; 191: 160617.
  • 34
    Freeberg J, Serachitopol D, McKinnon N, Price R, Atkinson E, Cox D, MacAulay C, Richards-Kortum R, Follen M, Pikkula B. Fluorescence and reflectance device variability throughout the progression of a phase II clinical trial to detect and screen for cervical neoplasia using a fiber optic probe. J Biomed Opt 2007; 12: 034015.
  • 35
    Marin N, MacKinnon N, MacAulay C, Chang SK, Atkinson EN, Cox D, Serachitopol D, Pikkula B, Follen M, Richards-Kortum R. Calibration standards for multicenter clinical trials of fluorescence spectroscopy for in vivo diagnosis. J Biomed Opt 2006; 11: 014010.
  • 36
    Pham B, Rhodes H, Milbourne A, Adler-Storthz K, Follen M, Scheurer ME. Epidemiologic differentiation of diagnostic and screening populations for the assessment of cervical dysplasia using optical technologies. DrexelMed J, in press.
  • 37
    Pham B, Earle N, Rabel K, Follen M, Scheurer ME. Maximizing the diversity of participants in a phase II clinical trial of optical technologies to detect cervical neoplasia. Gynecol Oncol 2007; 107: S20814.
  • 38
    Chang SK, Dawood M, Staerkel G, Utzinger U, Atkinson EN, Richards-Kortum R, Follen M. Fluorescence spectroscopy for cervical precancer detection: is there variance across the menstrual cycle? J Biomed Opt 2002; 7: 595602.
  • 39
    Cox D, Chang SK, Dawood M, Staerkel G, Utzinger U, Richards-Kortum R, Follen M. Detecting the signal of the menstrual cycle in fluorescence spectroscopy of the cervix. Appl Spectrosc 2003; 57: 6772.
  • 40
    MacAulay C, Richards-Kortum R, Utzinger U, Fedyk A, Atkinson E, Cox D, Follen M. Variation of fluorescence spectroscopy during the menstrual cycle. Opt Express 2002; 10: 493504.
  • 41
    Malpica A, Matisic JP, Niekirk DV, Crum CP, Staerkel GA, Yamal JM, Guillaud MH, Cox DD, Atkinson EN, Adler-Storthz K, Poulin NM, Macaulay CA, et al. Kappa statistics to measure interrater and intrarater agreement for 1790 cervical biopsy specimens among twelve pathologists: qualitative histopathologic analysis and methodologic issues. Gynecol Oncol 2005; 99: S3852.
  • 42
    Basen-Engquist K, Shinn EH, Warneke C, de Moor C, Le T, Richards-Kortum R, Follen M. Patient distress and satisfaction with optical spectroscopy in cervical dysplasia detection. Am J Obstet Gynecol 2003; 189: 113642.
  • 43
    Shinn EH. Provider satisfaction regarding cervical fluorescence spectroscopy. DrexelMed J, In press.
  • 44
    Cantor SB, Mitchell MF, Tortolero-Luna G, Bratka CS, Bodurka DC, Richards-Kortum R. Cost-effectiveness analysis of diagnosis and management of cervical squamous intraepithelial lesions. Obstet Gynecol 1998; 91: 2707.
  • 45
    Cárdenas-Turanzas M, Freeberg JA, Benedet JL, Atkinson EN, Cox DD, Richards-Kortum R, MacAulay C, Follen M, Cantor SB. The clinical effectiveness of optical spectroscopy for the in vivo diagnosis of cervical intraepithelial neoplasia: where are we? Gynecol Oncol 2007; 107: S13846.
  • 46
    Freeberg JA, Benedet JL, MacAulay C, West LA, Follen M. The performance of fluorescence and reflectance spectroscopy for the in vivo diagnosis of cervical neoplasia; point probe versus multispectral approaches. Gynecol Oncol 2007; 107: S24855.
  • 47
    Shuhatovich OM, Sharman MP, Mirabal YN, Earle NR, Follen M, Basen-Engquist K. Participant recruitment and motivation for participation in optical technology for cervical cancer screening research trials. Gynecol Oncol 2005; 99: S22631.
  • 48
    Manos M, Ting Y, Wright D, Lewis A, Broker T, Wolinsky S. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989; 7: 20914.
  • 49
    Scheurer M, Dillon L, Chen Z, Follen M, Adler-Storthz K. Absolute quantitative real-time polymerase chain reaction for the measurement of human papillomavirus E7 mRNA in cervical cytobrush specimens. Infect Agent Cancer 2007; 2: 8.
  • 50
    Cárdenas-Turanzas M, Nogueras-Gonzalez G, Scheurer M, Adler-Storthz K, Benedet J, Beck J, Follen M, Cantor S. The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings. Cancer Epidemiol Biomarkers Prev 2008; 17: 286571.
  • 51
    Cárdenas-Turanzas M, Follen M, Nogueras-Gonzalez G, Benedet J, Beck J, Cantor S. The accuracy of the Papanicolaou smear in the screening and diagnostic settings. J Low Genital Tract Dis 2008; 12: 26975.
  • 52
    Guillaud M, Benedet J, Cantor S, Staerkel G, Follen M, MacAulay C. DNA ploidy compared with human papilloma virus testing (hybrid capture II) and conventional cervical cytology as a primary screening test for cervical high-grade lesions and cancer in 1555 patients with biopsy confirmation. Cancer 2006; 107: 30918.
  • 53
    Hastie T, Tibshirani R, Friedman J. The elements of statistical learning: data mining, inference, and prediction, 2nd ed. New York: Springer, 2009.
  • 54
    Pepe M. The statistical evaluation of medical tests for classification and prediction, 1st ed. New York: Oxford University Press, 2004.
  • 55
    Janes H, Pepe M. Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting. University of Washington, Biostatistics Working Paper Series, 2007.
  • 56
    Redden Weber C, Schwarz RA, Atkinson EN, Cox DD, Macaulay C, Follen M, Richards-Kortum R. Model-based analysis of reflectance and fluorescence spectra for in vivo detection of cervical dysplasia and cancer. J Biomed Opt 2008; 13: 064016.
  • 57
    Zhu H, Vannucci M, Cox DD. A Bayesian hierarchical model for classification with selection of functional predictors. Biometrics 2010; 66: 46373.
  • 58
    Zhu H, Cox D. A functional generalized linear model with curve selection in cervical pre-cancer diagnosis using fluorescence spectroscopy. In: Rojo J, ed. Optimality: the third Erich L. Lehmann symposium. Beachwood, Ohio: Institute of Mathematical Statistics, 2009: 17389.
  • 59
    Weingandt H, Stepp H, Baumgartner R, Diebold J, Xiang W, Hillemanns P. Autofluorescence spectroscopy for the diagnosis of cervical intraepithelial neoplasia. BJOG 2002; 109: 94751.
  • 60
    Ramanujam N, Mitchell MF, Mahadevan A, Thomsen S, Silva E, Richards-Kortum R. Fluorescence spectroscopy: a diagnostic tool for cervical intraepithelial neoplasia (CIN). Gynecol Oncol 1994; 52: 318.
  • 61
    Ramanujam N, Mitchell MF, Mahadevan A, Thomsen S, Malpica A, Wright T, Atkinson N, Richards-Kortum R. Development of a multivariate statistical algorithm to analyze human cervical tissue fluorescence spectra acquired in vivo. Lasers Surg Med 1996; 19: 4662.
  • 62
    Ramanujam N, Mitchell MF, Mahadevan A, Thomsen S, Malpica A, Wright T, Atkinson N, Richards-Kortum R. Spectroscopic diagnosis of cervical intraepithelial neoplasia (CIN) in vivo using laser-induced fluorescence spectra at multiple excitation wavelengths. Lasers Surg Med 1996; 19: 6374.
  • 63
    Mitchell MF, Cantor SB, Ramanujam N, Tortolero-Luna G, Richards-Kortum R. Fluorescence spectroscopy for diagnosis of squamous intraepithelial lesions of the cervix. Obstet Gynecol 1999; 93: 46270.
  • 64
    Mitchell MF, Cantor SB, Brookner C, Utzinger U, Schottenfeld D, Richards-Kortum R. Screening for squamous intraepithelial lesions with fluorescence spectroscopy. Obstet Gynecol 1999; 94: 88996.
  • 65
    Belinson J, Qiao YL, Pretorius R, Zhang WH, Elson P, Li L, Pan QJ, Fischer C, Lorincz A, Zahniser D. Shanxi province cervical cancer screening study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001; 83: 43944.
  • 66
    Parker M, Mooradian G, Karins J, O'Connor D, Speer B, Owensby P. Hyperspectral diagnostic imaging of the cervix: report on a new investigational device. J Low Genit Tract Dis 2000; 4: 11924.
  • 67
    Parker MF, Mooradian GC, Okimoto GS, O'Connor DM, Miyazawa K, Saggese SJ. Initial neural net construction for the detection of cervical intraepithelial neoplasia by fluorescence imaging. Am J Obstet Gynecol 2002; 187: 398402.
  • 68
    Wright T, Ferenczy A, Wray S, Christianson R, Ganguly D. Abstracts presented for the thirtieth annual meeting of the Society of Gynecologic Oncologists: detection of cervical squamous intraepithelial lesions using evoked tissue fluorescence. Gynecol Oncol 1999; 72: 458.
  • 69
    Dattamajumdar AK, Wells D, Parnell J, Lewis JT, Ganguly D, Wright TC, Jr. Preliminary experimental results from multi-center clinical trials for detection of cervical precancerous lesions using the Cerviscan™ system: a novel full-field evoked tissue fluorescence based imaging instrument. 23rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2001; 3: 315052.
  • 70
    Coppleson M, Reid BL, Skladnev VN, Dalrymple JC. An electronic approach to the detection of pre-cancer and cancer of the uterine cervix: a preliminary evaluation of Polarprobe. Int J Gynecol Cancer 1994; 4: 7983.
  • 71
    Singer A, Coppleson M, Canfell K, Skladnev V, Mackellar G, Pisal N, Deery A. A real time optoelectronic device as an adjunct to the Pap smear for cervical screening: a multicenter evaluation. Int J Gynecol Cancer 2003; 13: 80411.
  • 72
    Mirabal YN, Chang SK, Atkinson EN, Malpica A, Follen M, Richards-Kortum R. Reflectance spectroscopy for in vivo detection of cervical precancer. J Biomed Opt 2002; 7: 58794.
  • 73
    Mourant J, Bocklage T, Powers T, Greene H, Bullock K, Marr-Lyon L. In vivo light scattering measurements for detection of precancerous conditions of the cervix. Gynecol Oncol 2007; 105: 43945.
  • 74
    Orfanoudaki I, Themelis G, Sifakis S, Fragouli D, Panayiotides J, Vazgiouraki E. A clinical study of optical biopsy of the uterine cervix using a multi-spectral imaging system. Gynecol Oncol 2005; 96: 11931.
  • 75
    Georgakoudi I, Sheets EE, Muller MG, Backman V, Crum CP, Badizadegan K, Dasari RR, Feld MS. Trimodal spectroscopy for the detection and characterization of cervical precancers in vivo. Am J Obstet Gynecol 2002; 186: 37482.
  • 76
    Ferris D, Lawhead R, Dicjman E, Holtzapple N, Miller J, Grogan S, Bambot S, Agrawal A, Faupel M. Multimodal hyperspectral imaging of the noninvasive diagnosis of cervical neoplasia. J Low Genit Tract Dis 2001; 5: 6572.
  • 77
    DeSantis T, Chakhtoura N, Twiggs L, Ferris D, Lashgari M, Flowers L. Spectroscopic imaging as a triage test for cervical disease: a prospective multicenter clinical trial. J Low Genit Tract Dis 2007; 11: 1824.
  • 78
    Burke L, Niloff J, Kobelin M, Abu-Jawdeh G, Zelenchuk A, Modell M. Use of autofluorescence of cells to evaluate cervical neoplasia. J Gynecol Tech 1996; 2: 90.
  • 79
    Burke L, Modell M, Niloff J, Kobelin M, Abu-Jawdeh G, Zelenchuk A. Identification of squamous intraepithelial lesions: fluorescence of cervical tissue during colposcopy. J Low Genit Tract Dis 1999; 3: 15962.
  • 80
    Nordstrom R, Burke L, Niloff J, Myrtle J. Identification of cervical intraepithelial neoplasia (CIN) using UV-excited fluorescence and diffuse-reflectance tissue spectroscopy. Lasers Surg Med 2001; 29: 11827.
  • 81
    Huh WK, Cestero RM, Garcia FA, Gold MA, Guido RS, McIntyre-Seltman K, Harper DM, Burke L, Sum ST, Flewelling RF, Alvarez RD. Optical detection of high-grade cervical intraepithelial neoplasia in vivo: results of a 604-patient study. Am J Obstet Gynecol 2004; 190: 124957.
  • 82
    Alvarez RD, Wright T. Effective cervical neoplasia detection with a novel optical detection system: a randomized trial. Gynecol Oncol 2007; 104: 2819.
  • 83
    Benavides J, Chang S, Park S, Richards-Kortum R, Mackinnon N, MacAulay C, Milbourne A, Malpica A, Follen M. Multispectral digital colposcopy for in vivo detection of cervical cancer. Opt Express 2003; 11: 122336.
  • 84
    Milbourne A, Park SY, Benedet JL, Miller D, Ehlen T, Rhodes H, Malpica A, Matisic J, Van Niekirk D, Atkinson EN, Hadad N, Mackinnon N, et al. Results of a pilot study of multispectral digital colposcopy for the in vivo detection of cervical intraepithelial neoplasia. Gynecol Oncol 2005; 99: S6775.
  • 85
    Park SY, Follen M, Milbourne A, Rhodes H, Malpica A, MacKinnon N, MacAulay C, Markey M, Richards-Kortum R. Automated image analysis of digital colposcopy for the detection of cervical neoplasia. J Biomed Opt 2008; 13: 014029.
  • 86
    Nakappan S, Park SY, Serachitopol D, Price R, Cardeno M, Au S, Mackinnon N, MacAulay C, Follen M, Pikkula BM. Methodology of a real-time quality control for the multispectral digital colposcope (MDC). Gynecol Oncol 2007; 107: S21522.